ArticleInternational journal of biological sciences2026
Targeting Mitochondrial PD-L1 O-GlcNAcylation to Sensitize HBV-Related HCC to Immunotherapy: Modulating Golgi-mitochondrial Crosstalk and mTOR/PGC-1α-Driven Mitochondrial Biogenesis to Overcome Resistance.
Ze-Bang Du et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.